Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "Scutellariae radix" patented technology

Scutellaria baicalensis in particular is a common component of many preparations. Its root, known as Radix Scutellariae, is the source of the Chinese medicine Huang Qin. It has been in use for over 2000 years as a remedy for such conditions as hepatitis, diarrhea, and inflammation.

A traditional Chinese medicine composition for treating ulcerative colitis, a preparation method and use thereof

ActiveCN118767087BAconitum carmichaeliAdjuvant
This invention relates to the field of traditional Chinese medicine (TCM) technology, and discloses a TCM composition for treating ulcerative colitis, its preparation method, and its uses. The TCM composition comprises the following raw materials in parts by weight: 2-10 parts of charred Typhae Pollen, 3-7 parts of charred Scutellariae Radix, 4-6 parts of charred Angelicae Sinensis Radix, 3-8 parts of charred Sophorae Fructus, 6-10 parts of Prunus Mume, 2-10 parts of prepared Zingiberis Rhizoma, 5-7 parts of prepared Aconitum Carmichaelii Radix, 3-7 parts of Coptise Rhizoma, and 1-8 parts of Indigo Naturalis Radix. Among these, Prunus Mume is the principal ingredient, with prepared Zingiberis Rhizoma and prepared Aconitum Carmichaelii Radix as assistant ingredients, and charred Angelicae Sinensis Radix, charred Sophorae Fructus, charred Typhae Pollen, charred Scutellariae Radix, Coptise Rhizoma, and Indigo Naturalis as adjuvants. The synergistic effect among the various TCM components gives the TCM composition of this invention the effects of soothing the liver and strengthening the spleen, astringing the intestines and stopping bleeding. It is mainly used to treat moderate to severe ulcerative colitis. Experiments have demonstrated that the traditional Chinese medicine composition of this invention can inhibit intestinal inflammatory response in mice with ulcerative colitis; improve pathological histological damage and promote intestinal mucosal repair; regulate macrophage polarization and restore the balance of M1 / M2 macrophages; regulate CD4+ T cell differentiation and reshape Th17 / Treg cell immune homeostasis.
Owner:DONGFANG HOSPITAL BEIJING UNIV OF CHINESE MEDICINE

A topical traditional Chinese medicine composition for treating hand-foot syndrome caused by antitumor drugs

PendingCN122097475ADermatological disorderPlant ingredientsCommiphora myrrha resinScutellariae radix
The application belongs to the field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition for treating hand-foot syndrome caused by antitumor drugs. The application takes 'clearing heat and resolving toxins, cooling blood and activating blood, and astringing and promoting muscle regeneration' as the core principle, constructs a whole-cycle management system from early prevention and intervention to late ulcer repair, and provides a traditional Chinese medicine treatment scheme with pertinence and practicability for patients with hand-foot syndrome caused by antitumor drugs. The traditional Chinese medicine composition is composed of Qingdai, Phellodendri Cortex, Scutellariae Radix, Sanguisorba officinalis, Arnebia euchroma, Boswellia sacra, Commiphora myrrha and Glycyrrhiza uralensis. The traditional Chinese medicine composition has the advantages of reducing the classification of hand-foot syndrome, effectively relieving the pain symptoms of patients, and steadily improving the quality of life of patients.
Owner:SHANGHAI FOURTH PEOPLES HOSPITAL (SHANGHAI FOURTH PEOPLES HOSPITAL AFFILIATED TO TONGJI UNIV)